Related Experiment Video

Updated: Aug 9, 2026

Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis
09:44

Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis

Published on: June 13, 2021

Unresolved issues in the biochemical pharmacology of antifolates

R C Jackson1

  • 1Chemotherapy Department, Warner-Lambert/Parke-Davis Pharmaceutical Research, Ann Arbor, MI 48105.

NCI Monographs : a Publication of the National Cancer Institute
|January 1, 1987
PubMed

Insights

Fundamental questions persist regarding antifolate chemotherapy, including why cells die instead of entering stasis and the precise mechanisms of action for both classical and nonclassical antifolates, impacting optimal cancer treatment strategies.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Oncology

Background:

  • Antifolate drugs are crucial in cancer therapy, but their precise mechanisms of action and selectivity remain incompletely understood.
  • Classical antifolates like methotrexate (MTX) have known molecular targets, yet key questions about cell death pathways and side effects persist.
  • Nonclassical antifolates present further complexities regarding cellular uptake, polyglutamylation, and resistance mechanisms.

Purpose of the Study:

  • To address fundamental unanswered questions in antifolate pharmacology and anticancer selectivity.
  • To clarify the molecular basis for cell death induced by antifolates, moving beyond simple stasis.
  • To elucidate the mechanisms of action and selectivity for both classical and nonclassical antifolates, including transport and resistance.

Main Methods:

  • Review and discussion of existing literature on antifolate mechanisms.
  • Analysis of molecular pharmacology data for classical and nonclassical antifolates.
  • Exploration of drug transport, metabolism (polyglutamylation), and resistance pathways.

Main Results:

  • The exact reasons for antifolate-induced cell death versus stasis are not fully clarified.
  • The role of uracil misincorporation into DNA and the antipurine effects of MTX require further elucidation.
  • Mechanisms of cellular uptake, resistance, and cross-resistance for nonclassical antifolates like trimetrexate remain largely unknown.

Conclusions:

  • Significant gaps in knowledge hinder the design of optimal antifolate chemotherapy regimens.
  • Further research is needed to understand antifolate-induced cell death, drug transport, and resistance.
  • Clarifying these molecular details is essential for improving the efficacy and safety of antifolate-based cancer treatments.

More Related Videos

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

Unveiling Xenobiotic Transport and Effects in Isolated Mitochondria: Insights from Respirometric and Enzymatic Assays08:03

Unveiling Xenobiotic Transport and Effects in Isolated Mitochondria: Insights from Respirometric and Enzymatic Assays

Published on: March 7, 2025

Related Concept Videos

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...